These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30827923)

  • 1. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
    BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey.
    Puneet K; Tilburt JC; Volk RJ; Bennett CL; Qureshi Z; Gershman B; Sedlacek HM; Kim SP
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13301. PubMed ID: 33112008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
    Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
    BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
    Gershman B; Maroni P; Tilburt JC; Volk RJ; Konety B; Bennett CL; Kutikov A; Smaldone MC; Chen V; Kim SP
    World J Urol; 2019 Oct; 37(10):2099-2108. PubMed ID: 30671637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Care Related to Post-Operative Radiotherapy for Patients with Prostate Cancer among Canadian Radiation Oncologists and Urologists.
    Bristow B; Aldehaim M; Bonin K; Lam CCK; Wan SJ; Cao X; Szumacher E
    J Cancer Educ; 2018 Dec; 33(6):1195-1200. PubMed ID: 28573519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
    Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
    Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.
    Bandini M; Nazzani S; Marchioni M; Preisser F; Tian Z; Moschini M; Abdollah F; Suardi N; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Feb; 17(1):72-78.e4. PubMed ID: 30342845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.
    Gilfrich C; May M; Braun KP; Lebentrau S; Lehsnau M; Ecke T; Schmailzl KJ; Al-Dumaini S; Hallmann S; Ahmed AM; Maurer J; Karl T; Braun V; Haferkamp A; Brookman-May S; Bauer RM; Stief CG; Hoschke B; Maurer O; Wolff I
    Urol Int; 2014; 93(2):160-9. PubMed ID: 24603136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil.
    Wroclawski ML; Amaral BS; Kayano PP; Busato WFS; Westphal SJ; Montagna E; Bianco B; Soares A; Maluf FC; Lemos GC; Carneiro A
    BMC Urol; 2022 Jun; 22(1):86. PubMed ID: 35706024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
    Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.